prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
57015,1.80246110000e+16,97040020,6,Terlipressin 1mg/8.5ml solution for injection ampoules,Terlipressin acetate,120microgram/1ml,Solution for injection,Intravenous,Posterior Pituitary Hormones,September 2013,17143001,,,,,,,,,0,6050201
68778,3.34221110000e+16,70570021,546,Desmopressin 25microgram oral lyophilisates sugar free,Desmopressin acetate,25microgram,Oral lyophilisate,Sublingual,Posterior Pituitary Hormones,February 2017,70570021,,,,,,,,,0,6050201
69072,3.34060110000e+16,70571021,319,Noqdirna 25microgram oral lyophilisates (Ferring Pharmaceuticals Ltd),Desmopressin acetate,25microgram,Oral lyophilisate,Sublingual,Posterior Pituitary Hormones,March 2017,70571021,,,,,,,,,0,6050201
47274,4824911000001106,66912020,0,Glypressin 1mg powder and solvent for solution for injection vials (Ferring Pharmaceuticals Ltd),Terlipressin acetate,1mg,Powder and solvent for solution for injection,Intravenous,Posterior Pituitary Hormones,May 2012,4793001,,,,,,,,,0,6050201
48067,325929006,66910020,2,Terlipressin 1mg powder and solvent for solution for injection vials,Terlipressin acetate,1mg,Powder and solvent for solution for injection,Intravenous,Posterior Pituitary Hormones,November 2012,4792001,,,,,,,,,0,6050201
68837,3.34055110000e+16,70573021,126,Noqdirna 50microgram oral lyophilisates (Ferring Pharmaceuticals Ltd),Desmopressin acetate,50microgram,Oral lyophilisate,Sublingual,Posterior Pituitary Hormones,February 2017,70573021,,,,,,,,,0,6050201
68768,3.34222110000e+16,70572021,518,Desmopressin 50microgram oral lyophilisates sugar free,Desmopressin acetate,50microgram,Oral lyophilisate,Sublingual,Posterior Pituitary Hormones,February 2017,70572021,,,,,,,,,0,6050201
